Fougera Pharmaceuticals is a company focusing on specialty pharmaceuticals in dermatology and manufacturing topical pharmaceutical products. It operates in two divisions: Fougera, its generic dermatology medicines business, and PharmaDerm, its branded dermatology business. The Fougera division is a manufacturer and distributor of a wide range of topical products. The PharmaDerm division is dedicated to developing and commercializing novel prescription products to treat diseases and conditions of the skin. Fougera separated from former parent Nycomed International and was acquired by Sandoz, a division of Novartis.